Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Aminosalicylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | GAA | P10253 | 2/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 2/20 | 1.00 |
| ▸ | ESR2 | Q92731 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.69 |
| ▸ | HPGD | P15428 | 5/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.69 |
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | KDR | P35968 | 2/20 | 0.69 |
| ▸ | THRB | P10828 | 2/20 | 0.69 |
| ▸ | RECQL | P46063 | 2/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.69 |
| ▸ | TNF | P01375 | 1/20 | 0.69 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.69 |
| ▸ | CASP1 | P29466 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aminosalicylic Acid SCHEMBL29450213 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| Aminosalicylic Acid SCHEMBL3333393 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| Aminosalicylic Acid SCHEMBL30337954 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| Aminosalicylic Acid SCHEMBL29030136 | 0.98 | ALDH1A1 (0.96) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| Aminosalicylic Acid SCHEMBL1047422 | 0.98 | ALDH1A1 (0.96) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| Aminosalicylic Acid SCHEMBL11788850 | 0.98 | ALDH1A1 (0.96) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| Aminosalicylic Acid SCHEMBL564092 | 0.98 | ALDH1A1 (0.96) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| Aminosalicylic Acid SCHEMBL28886739 | 0.98 | ALDH1A1 (0.96) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| Aminosalicylic Acid SCHEMBL2347251 | 0.98 | ALDH1A1 (0.96) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| Aminosalicylic Acid SCHEMBL8615264 | 0.98 | ALDH1A1 (0.96) | ALDH1A1KDM4EMAPTCYP3A4GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 55905 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120078790-B | Use of heterocyclic compounds | WUHAN INSTITUTE OF VIROLOGY, CHINESE ACADEMY OF SCIENCES (CN) | 2026-05-26 | — | — | CN | claimed |
| WO-2026103879-A1 | USE OF BIPHENYL-CONTAINING COMPOUND FOR TREATING INFLAMMATORY BOWEL DISEASE | 正大天晴药业集团股份有限公司 | 2026-05-21 | — | — | WO | claimed |
| WO-2026103747-A1 | SALT OF THIAZOLE DERIVATIVE INHIBITOR, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF | 江苏豪森药业集团有限公司 | 2026-05-21 | — | — | WO | claimed |
| CN-121550254-B | Pharmaceutical composition for improving pancreatic cancer treatment effect | 浙江省肿瘤医院 | 2026-05-15 | — | — | CN | claimed |
| CN-122036704-A | Free base crystal form or acid salt of biaryl compound, preparation method and medical application thereof | 江苏豪森药业集团有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026102031-A1 | PASYLATED URICASE VARIANTS AND METHODS OF USE THEREOF | INSMED INCORPORATED (US) | 2026-05-15 | — | — | WO | claimed |
| CN-122010028-A | Penicillin bottle uncovering method and system for automatic dispensing machine | 美蓝(杭州)医药科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12624050-B2 | Three fused ring derivative-containing salt or crystal form and pharmaceutical composition thereof | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2026-05-12 | — | — | US | claimed |
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| US-12616691-B2 | Use of fatty acid oxidation inhibitors as antimicrobials | WASHINGTON UNIVERSITY IN ST. LOUIS (US) | 2026-05-05 | — | — | US | claimed |
| US-4147776-A | COORDINATION COMPLEX WITH AN ALKALI METAL SULFITE | MUNDIPHARMA, AG (CH) | 1979-04-03 | — | — | US | claimed |
| US-4025609-A | CHELATION | KAO SOAP CO., LTD. (JA) | 1977-05-24 | — | — | US | claimed |
| US-4017631-A | MICROBIOCIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1977-04-12 | — | — | US | claimed |
| US-4011220-A | PYRIDAZINIUM COMPOUNDS AND A PROCESS FOR THEIR PRODUCTION | BASF AKTIENGESELLSCHAFT (DT) | 1977-03-08 | — | — | US | claimed |
| US-3991202-A | ANTIMICROBIALS | JANSSEN PHARMACEUTICA N.V. (BE) | 1976-11-09 | — | — | US | claimed |
| US-3983209-A | HYDROPHOBIC BIOERODIBLE POLYMER, MICROBIOCIDE OR PROTEOLYTIC ENZYME | ALZA CORPORATION (US) | 1976-09-28 | — | — | US | claimed |
| US-3980633-A | PESTICIDES | BASF AKTIENGESELLSCHAFT (DT) | 1976-09-14 | — | — | US | claimed |
| US-3960536-A | MIXED CHELATE WITH AT LEAST TWO COORDINATES | PEPRO, SOCIETE POUR LE DEVELOPPEMENT ET LA VENTE DE SPECIALITES CHIMIQUES (FR) | 1976-06-01 | — | — | US | claimed |
| US-3959253-A | β-D-glucosyluronic acid derivatives | MERCK & CO., INC. (US) | 1976-05-25 | — | — | US | claimed |
| US-3954533-A | NITROCELLULOSE, NITROGLYCERIN AND BALLISTIC MODIFIERS OF LEAD- AND COPPER- SALTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1976-05-04 | — | — | US | claimed |